




SCREENING FOR GENETIC DISEASES: WHAT ARE THE 
MORAL CONSTRAINTS? 
Now that the Human Genome Project (HGP) is an ongoing and rapidly 
progressing reality, and human genetic engineering is expected to become 
standard procedure, the inevitable question is how will these procedures 
be applied. The inevitable and much debated answer is eugenics. It is 
often looked upon as positive eugenics, directed perhaps, towards 
achieving human beings endowed with optimal characteristics of physical 
strength and beauty, intellectual genius and longevity. There is of course 
the immense and probably insoluble problem of determining which 
human characteristics, among nature's rich and superb diversity, can be 
improved and what constitutes the hypothetical physical and intellectual 
excellence that one might envisage and enhance. 
Assuming, purely for the sake of argument, that it would be possible to 
achieve this excellence, for ourselves and for our future offspring, 
through genetic engineering, there would immediately arise two signifi-
I cant moral problems. The first would arise from the great likelihood that 
the vast majority of us would rush to be genetically engineered, creating 
the moral problem of who should have priority. The second is, that those 
of us who did not have the privilege of being genetically engineered, or 
did not have the natural endowment of perfection, would somehow be 
considered as inferior, second-rate human beings raising the other serious 
moral worry of discrimination. 
Being simply a pratticing geneticist who sees an abundance of prob-
lems of genetically induced misery, I must confess that my competence in 
speaking about achieving such perfection is limited. My eugenic priorities 
dictate that I limit myself to a discussion of the prevention and correction 
of genetic diseases as a contribution to eugenics for the future. As a 
geneticist who witnesses some of the most distressing diseases which 
affect mankind, including the birth of congenitally malformed infants and 
.. serious, incapacitating and often lethal genetic diseases; who feels the 
psychological trauma experienced by parents as a result of the knowledge 
that one or both of them were agents in the genetic transmission of dis-
ease, I cannot help but think that negative eugenics (or the prevention of 
J genetic disease) is, and will remain for a considerable time, the priority 
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with respect to future generations. The great strides currently being made 
in the field of genetic screening is directed precisely towards alerting 
geneticists to the presence of disease-producing genes as a first step in the 
prevention of genetic disease and thus contributing to eugenics concern-
ing future generations. 
It cannot be denied that the development of human genetics and its 
remarkable achievements have been spurred on by the relentless quest to 
find the underlying causes of genetic and inherited diseases and to find 
remedies for these hitherto untreatable conditions. This is the present 
ambition of most geneticists and scientists, as can be witnessed by their 
contributions to the immense literature on genetics. It is a positive contri-
bution: to improve the present gene pool which is the one that will be 
passed on to future generations. 
Given the considerable advances taking place in gene technology, the 
prospects of genetic engineering and particularly of germ-cell engineer-
ing, can we feel confident that we will live up to our responsibilities 
towards future generations? Is there cause for concern when one consid-
ers the prospects of positive eugenics, of creating clones and designer 
babies? In trying to assess the gravity of the situation one should start by 
assessing what the present generation of geneticists and scientists are 
doing and what direction is being taken, because this is what is within our 
capabilities to oversee. It is our responsibility to guard the present gene 
pool and ensure, in the most cautious and enlightened way possible, that 
nothing is done which may be detrimental to future generations, and that 
necessary measures are taken to implement any positive measures for its 
enhancement. Should we concern ourselves with what might happen in 
the future and think of ways in which such eventualities might need to be 
dealt with? 
My thesis is that the greatest positive contribution that we can make to 
future generations lies in the present. Genes are transmitted one genera-
tion at a time. The present genes are the ones which can be modified by 
the present generation of geneticists and scientists in ways that could be 
beneficial or detrimental to future generations. How scientists might 
behave or react in the future is not within our control. However, it is 
within the responsibility and control of the present generation to criticize-
the values that emerge from the vast and rapidly expanding field of 
human genetics and genetic technology, and perhaps to set the trend in 
the development and evolution of thought regarding future projects. 





SCREENING FOR GENETIC DISEASES 5 
arise should we conduct genetic interventions to enhance desirable char-
acteristics, but I shall dwell on the more mundane and practical issues of 
what we can do, and what we are doing now, and how we could benefit 
future generations. 
The HGP is the major landmark and turning point of the present time. 
It is meant to ensure that there is a complete map, catalogue, and se-
quence of the 100,000 (or probably much more) estimated genes in the 
human genome, how they function, and how they interact with one 
another. The project is also expected to provide important information 
about the large amount of non-coding genetic DNA which apparently 
does not carry genetic messages in the conventional sense, that is genes 
for the synthesis of proteins. This vast amount of largely unexplored 
DNA certainly holds many yet untold secrets about gene interaction and 
control. The HGP is expected to provide a better understanding of the 
common heritable traits which do not appear to be attributable to single 
genes, such as stature, intelligence, obesity, and others. Above all, it is 
expected to form the basis and the main reference point for investigating 
inherited and acquired disease, human development, and evolution. 
When the HGP is completed we would be in a position to say that we 
understand human life much better than ever before; that we have a grasp 
on the mechanisms operating in the human genome. Equipped with all 
this knowledge man would have control over his own genome and would 
be able to manipulate it. However, we need not wait until the project is 
completed. The HGP has already started, and although there is still a long 
way to go to its full realization, it has already yielded results and its 
effects are already being felt. 
The genes for a number of serious diseases have already been mapped, 
cloned, and sequenced. This has made possible genetic testing for quite a 
number of genetic diseases. Genetic testing has already been with us for 
quite some time. The moral and ethical problems encountered in the 
course of such testing are therefore not new. However, their magnitude 
has increased and will continue to increase in proportion to the increase in 
our knowledge of genes and their mutations. 
Advances in genetic technology not only increased the number of tests 
"'for genetic diseases, but also made the testing simpler and less costly so 
that large scale genetic screening has become a possibility and can even 
be extended to populations. 
The greatest moral problems that arise from the ability to test for 
human genetic disease are (as Baroness Warnock points out) problems of 
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knowledge. Genetic testing is simply the availability of knowledge about 
the genetic constitution of a particular individual. The problems arise 
from the implications of such knowledge to the individual concerned, to 
his or her family, to third parties, and to society in general. Who has the 
right to such knowledge? Who should decide whether genetic information 
about an individual is to be obtained or not? That is, who is to decide 
whether a particular individual should be tested or not? Who should 
decide to whom this knowledge should be made available? Who should 
decide what actions are to be taken when a gene abnormality is discov-
ered? These problems are the main determining factors that impose moral 
constraints on the use of genetic testing in the future. 
I begin with the implications of genetic testing for the particular indi-
vidual. Inherited diseases which manifest themselves late in life are the 
ones in which these implications are most significant, but they can also be 
used as models for other diseases. Individuals who are afflicted with 
severe genetic diseases which appear late in life, such as Huntington's 
disease, experience the normality of life, the hardship of being afflicted 
with a serious and incapacitating disease, and the sorrow caused by the 
daunting prospects of transmitting the same disease to their children and 
to future generations. Huntington's disease appears late in life, usually 
after the reproductive years, and often after the individual has transmitted 
the deleterious genes to the next generation. It is possible to know, 
through genetic testing, whether a particular individual who is at risk is 
affected or not, and in my view, the individual should be free to make his 
or her own choice about whether to be tested, whether he or she would 
prefer the reality of knowledge to the uncertainty of chance. With the 
former, distressing as it might be, it would be possible for an individual to 
plan his or her life, including marriage and children. Some individuals, 
however, prefer not to be tested, to leave everything to chance, and to live ~ 
with the uncertainty of risk. The decision is expected to vary depending • 
on the individual and his or her family circumstances. One main factor is • 
whether the individual is already married and has children, or whether he a 
or she is considering marriage or having children. The present trend is 
that young individuals prefer to "face reality" before entering into rela-
tionships with other persons, and that marriage partners expect to know· 
the truth about their future spouse. 
Because it is essential to respect an individual's freedom of choice, it is 
generally accepted that the options for genetic testing are not extended to 
minors, except in situations where outcomes could be of direct and 
.. 
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immediate benefit to a child; as, for example, in a boy with muscular 
dystrophy or a child with familial intestinal polyposis which requires 
surveillance for possible malignant growth. 
The implications of being tested are serious, and the responsibilities 
are great, so that the individuals concerned need psychological support 
and adequate knowledge about the disease itself, the mutant genes and 
the possible implications, in order to be able to take responsible deci-
sions. In other words, the opportunity for testing brings with it the moral 
obligation of providing adequate support and counselling services. If 
these cannot be provided, it seems unethical to carry out genetic testing. 
What are the options for preventing the propagation of genetic dis-
eases? One time-honoured option is to voluntarily abstain from having 
children, a decision which must be entirely free and which should not, in 
my view, be forced upon prospective parents. Although this approach is 
usually adopted, couples often do feel the strain of not being able to have 
children, and typically seek alternatives. The second option is to elect 
selective abortion following prenatal diagnosis. The third option, which is 
now becoming more easily available, is pre-implantation diagnosis on a 
four-\or eight-cell embryo. One of these cells is removed by mi-
cro-techniques and its DNA amplified and tested. If it is found to carry 
the abnormal gene, the remaining embryonic cells are discarded; whereas 
if the tested cell is found to carry a normal gene, the embryo is implanted. 
These three methods of inhibiting the propagation of an abnormal gene 
are all methods of artificial selection against the disease gene. 
It is not appropriate to discuss here the moral issues which relate to 
selective abortion and pre-implantation diagnosis, procedures which some 
consider morally acceptable but others consider morally unacceptable, 
and therefore not really options for them. However, irrespective of the 
acceptability of the procedure itself, one questions whether it is morally 
right to terminate a pregnancy, whether in the pre- or post- implantation 
stage, because a disease may appear thirty to sixty years later. Besides, 
the condition may be treatable. Is it morally justifiable to deny life to an 
embryo or fetus because it is carrying a gene which predisposes to cancer, 
manic depressive psychosis or schizophrenia? All of these are undeniably 
serious diseases, but it should not be concluded that they necessarily 
make life not worth living. To carry the implications further, is it justifi-
able to deny life to a fetus because it carries a pre-mutation which does 
not cause any disease in the individual who carries it, but might manifest 
itself as a serious disease in future generations, such as may occur in 
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X-linked mental retardation? These are serious issues which confront us 
and which require responsible decisions, since they affect future genera-
tions. 
Besides, the very use of genetic testing and selective termination, 
rather like weeding a garden of unwanted specimens, is repulsive to many 
when applied to fellow human beings, and constitutes one of the worst 
forms of discrimination, imposing therefore one of the most serious moral 
constraints on the use of genetic testing and subsequent termination of 
pregnancy. 
What are the alternatives? Genetic engineering is expected to provide 
possible solutions. One of these might be germ-line cell genetic engineer-
ing intended to replace the mutant gene with a normal one. Once cor-
rected, the engineered germ-line cell would be expected to ensure that the 
disease is not transmitted to future generations. However, this approach is 
replete with uncertainties. Firstly, although a known defective gene may 
be successfully engineered in a germ-line cell, new mutations still con-
tinue to arise so that genetic diseases can only be limited to a certain 
extent. Secondly, genetics is only beginning to alert us to the fact that 
genes in germ cells may behave differently from those in somatic cells, 
and furthermore that they may behave differently in female and in male 
germ cells. These scientific uncertainties impose a grave moral constraint 
on the use of such procedures, which should not be employed until there 
is at least sufficient scientific knowledge about the genetics of germ cells 
to make germ-line genetic engineering a worthy proposition. Besides, 
genetic experimentation on germ cells which are subsequently fertilized 
would pose moral and ethical problems which are in many ways similar 
to experimentation on embryos. Because of these uncertainties, genetic 
engineering is, at present, not permissible on human germ cells. Neverthe-
less, these problems are not unsurmountable, and it is expected that in the 
future-germ line cell genetic engineering will become feasible and could 
make important contributions to the prevention of genetic disease. 
A feasible alternative to germ-cell engineering is expected to be ge-
netic engineering of the early embryo in its two-\or four-cell stage. Here, 
one is dealing with somatic cells but the results of the genetic engineering 
would also include the subsequent germ cells. Genetic engineering in 
embryos is considered to be a sophisticated and extremely delicate form 
of surgery intended to correct a defect, and at least prima facie would not 
appear to pre.sent serious moral constraints. 
It has already been stated that it is essential to maintain strict privacy in 
.. 
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genetic testing especially for adult-onset disorders which are to be per-
formed following the obtaining of infol1ned consent. However, it is 
rightly argued that the offspring, siblings, and other close relatives of an 
affected person have a right to know the results of genetic testing, be-
cause they too might be at risk. Pressures are also applied by insurance 
agencies and employers who claim that they have a right to know of 
existing genetic risks before entering into a contract with their customers. 
If these demands are acceded to they could easily amount to compulsory 
testing. These matters, presently strongly debated, are fundamentally 
concerned with the question of privacy, of who should decide on whether 
genetic testing is to be performed, and most importantly, with the issue of 
discrimination which might take the fonn of increased premiums, of 
denial of medical or life insurance, or work. Such considerations are more 
important in some countries where health services rely on private insur-
ance, but of less significance in countries like Malta where full health 
services are available to all. A similar problem of privacy arises when a 
population-wide screening program is proposed -for a common genetic 
disorder. This too might amount to compulsory testing. 
As genes for more and more diseases become known, and genetic 
screening becomes easier to perform, the pressures for indirect compul-
sory screening are bound to increase, though perhaps surreptitiously. It is 
imperative that such pressures be resisted, not only to guarantee confi-
dentiality of genetic data but above all to ensure that genetic screening is 
not misused as a form of discrimination. 
In assessing the most recent contributions of human genetics, we see 
that the most prominent advances have been in the field of medical 
genetics. This is not fortuitous but stems from the real and genuine ap-
preciation of the need to understand and eventually find remedies for 
serious genetic illnesses, which have for so long eluded us. Medical care 
has always been committed to preserving life and curing disease. This is 
not by any means an exclusive characteristic of medical people but 
merely a commitment to help others, just as people have committed 
themselves through their various professions to voluntarily care for the 
weak, the diseased, the disabled, the oppressed, the socially disadvan-
taged, and those who have been abused by others. It is true that some 
people have, on the contrary, committed themselves to greed. Why should 
we now doubt the good intentions of geneticists and scientists who have 
workecl ~md are still working to identify the basis of genetic disease and in 
the process are unravelling the fundamental structures of life? Should 
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they be mistrusted and treated as though they were irresponsible? 
Most of the concern that has been expressed regarding possible misuse 
of genetics to the detriment of future generations stems from the fact that 
exploration of the genome is largely exploration of unknown territory, 
which always brings with it a certain degree of fear and anxiety. How-
ever, danger is not really a deterrent but a challenge to proceed with 
caution. Many fears and concerns had been expressed in the 1970s when 
the first genes were cloned in bacteria; but scientists cautiously but stead-
ily carried on in their venture while concerned onlookers cried out 
DANGER! and even warned of impending doom. Scientists and institu-
tions responsible for their funding took the appropriate measures to 
ensure that scientists were self-critical and self-controlling. There was 
consensus on this matter at national and international levels. In 1989, at 
the Council of Europe, ministers of European countries agreed that 
"throughout the execution of the programme the ethical, social and legal 
aspects of human genome analysis should be the subject of wide ranging 
and in-depth discussions, and possible abuses of the results or later 
developments of the work should be identified. Principles for their utili-
zation and control should be proposed." It is incumbent on scientists, 
doctors, and others involved in research to ensure that the application of 
knowledge is for good purposes and that possible abuses are detected and 
stopped. Who can do this monitoring better than the scientists them-
selves? Who knows what is going on and who are in the best position to 
detect abuses? 
Now continuation of genetic research is leading to a better understand-
ing of human life, and ourselves. However, people are again expressing 
fear and mistrust of science and the powerful technology it creates. 
Again, this stems largely from fear of the unknown and feelings of threat 
from a powerful technology which is in the hands of scientists. We hear 
warnings of another impending calamity (due to the misuse of genetic 
engineering in human germ cells) posing a threat to the human genome of 
future generations unless action is taken to prevent it. But, we should stop 
and reflect. Is it realistic to think that scientists and geneticists involved in 
this tremendous project are so overwhelmed by the momentous discover-
ies that a "watchdog" is needed to oversee their activities? Is there really 
any threat to the genome of future generations, or is it time that we take 
count of the reality of the situation as it is at present? 
Organizations dedicated to protecting future generations usually have 
good intentions: to promote the view that what man has today (whether 
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this is cultural, environmental, or genetic) should be preserved, and 
possibly even enriched for future generations. At the moment, we are 
living up to our responsibilities of preserving the human genome and of 
passing it on to future generations. We must, however, evaluate the 
present situation of the human genome, give due recognition to beneficial 
achievements, and identify deleterious ones, doing all in our power to 
inhibit them. We must educate the public and dispel undue fears. The 
future heritage of mankind depends on what we do or fail to do today. 
There is no doubt that the most important applications of powerful 
genetic technology have been in the field of genetic diagnosis, and treat-
ment using genetic engineering is well on the way to new applications. 
These are the tremendous contributions of medical genetics to the control 
of human disease. There is no doubt that this ideal leads the list of 
eugenic priorities. Genetic testing is only one small but essential step 
toward achieving these priorities. Let us look forward with courage and 
optimism to achieving additional positive gains which will safeguard and 
enhance the future of humanity! 
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